NewBioRx Expands Pharmaceutical-Grade Peptide Pen Production to Meet Growing Demand From Research Institutions and Life Sciences Companies

NewBioRx, a pharmaceutical-grade peptide brand serving research institutions, life sciences companies, and biomedical ...

Peptides Calculator Brings AI Meal and Exercise Planning to Peptide Researchers

AI-generated meal and workout plans built from each researcher's own stats and labs — stored on device and in their own ...

How to Verify Peptide Purity: HPLC, Mass Spectrometry, and What to Demand From a Research-Grade Supplier

Learn how to verify research-grade peptide purity using HPLC, mass spectrometry, and Certificates of Analysis, plus the key ...

Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic ...

Vector Science & Therapeutics, Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced the expansion of its ...

Crispr Therapeutics: A Catalyst-Rich 12 Months Ahead

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...

TB-500 (TB4) Back in Stock at BioEdge Research Labs

July 20, 2026 - PRESSADVANTAGE - BioEdge Research Labs, LLC has announced the availability of TB-500 (TB4), now in ...
eLife

DNA tensiometer reveals catch-bond detachment kinetics of kinesin-1, -2, and -3

All three kinesin transport families exhibit unexpectedly slow dissociation under load, explaining robust competition with dynein during bidirectional cargo transport.